Lord, Abbett & Co
MRVI icon

Lord, Abbett & Co’s Maravai LifeSciences MRVI Stock Holding History

Lord, Abbett & Co’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-163,215
Closed -$8.01M – 661
2021
Q3 		$8.01M Sell
163,215
-1,110
-0.7% -$54.1K 0.02% 551
2021
Q2 		$6.86M Sell
164,325
-288,906
-64% -$11.2M 0.02% 584
2021
Q1 		$16.2M Buy
453,231
+304,483
+205% +$10.1M 0.04% 440
2020
Q4 		$4.17M Buy
+148,748
New +$4.14M 0.01% 605

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Lord, Abbett & Co's MRVI Position: Q4 2021 in Review

Lord, Abbett & Co sold out of Maravai LifeSciences (MRVI) in Q4 2021, closing a stake of 163,215 shares — an estimated $8.01M sold.

Lord, Abbett & Co first reported a position in MRVI in Q4 2020 and held it in 4 quarters. The position peaked at $16.2M in Q1 2021. 229 funds tracked by Wall St. Rank hold MRVI as of Q4 2021.

  • Lord, Abbett & Co reported no remaining Maravai LifeSciences position as of Q4 2021 after selling out during the quarter.
  • Lord, Abbett & Co sold 163,215 Maravai LifeSciences shares in Q4 2021, an estimated $8.01M.
  • Lord, Abbett & Co first reported a position in Maravai LifeSciences in Q4 2020 and held it in 4 quarters.
  • Lord, Abbett & Co's Maravai LifeSciences position peaked at $16.2M in Q1 2021.
  • 229 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2021.

Based on Lord, Abbett & Co's 13F filing for Q4 2021, filed 11 Feb 2022.